0000880771-16-000200.txt : 20161027 0000880771-16-000200.hdr.sgml : 20161027 20161027130006 ACCESSION NUMBER: 0000880771-16-000200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161025 FILED AS OF DATE: 20161027 DATE AS OF CHANGE: 20161027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cheung Wilson Wai-Shun CENTRAL INDEX KEY: 0001291656 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161954768 MAIL ADDRESS: STREET 1: SCICLONE PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2016-10-25 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001291656 Cheung Wilson Wai-Shun 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 CFO & Senior VP, Finance Common Stock 2016-10-25 4 S 0 70 10.00 D 15064 D Common Stock 2016-10-26 4 S 0 15064 10 D 0 D Common Stock 2016-10-26 4 M 0 45208 4.52 A 45208 D Common Stock 2016-10-26 4 S 0 45208 10 D 0 D Common Stock 2016-10-26 4 M 0 48995 5.97 A 48995 D Common Stock 2016-10-26 4 S 0 48995 10 D 0 D Common Stock 2016-10-26 4 M 0 40625 5.97 A 40625 D Common Stock 2016-10-26 4 S 0 40625 10 D 0 D Non-Qualified Stock Option (right to buy) 4.52 2016-10-26 4 M 0 45208 0 D 2024-03-14 Common Stock 45208 24792 D Non-Qualified Stock Option (right to buy) 5.97 2016-10-26 4 M 0 40625 0 D 2023-07-16 Common Stock 40625 9375 D Non-Qualified Stock Option (right to buy) 5.97 2016-10-26 4 M 0 48995 0 D 2023-08-09 Common Stock 48995 0 D The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2016. Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer. Provided Reporting Person remains employed by Issuer, the options will vest based upon the successful and timely filing by the SEC filing dates of the 10-Q and 10-Ks for the period from September 30, 2013 through the end of 2014, with the last 10-K filed for the year ending December 31, 2014 by March 16, 2015 (the "Performance Target"). If the Performance Target is not achieved, the options will not vest and will expire on March 17, 2015. /s/ Wilson W. Cheung 2016-10-27